CHEMPLASTS NSE filing

Chemplast Sanmar Q1 FY27 Earnings Call Transcript Released

The RealCase readMedium impact Neutral

Chemplast Sanmar reported Q1 FY27 consolidated revenue of ₹1,125 crore and an EBITDA loss of ₹115 crore due to high input costs. The company expects improved performance from Q3 as high-cost VCM inventory clears, with anticipated spreads of $160 for Suspension PVC and $200 for Paste PVC. Custom Manufactured Chemicals Division (CMCD) showed strong momentum, and refrigerant gas business is progressing.

Why it matters

The announcement provides an update on the company's financial performance and operational developments, including challenges faced in the PVC segment and positive traction in CMCD. This information is material for investors assessing the company's current standing and future prospects, warranting a medium impact.

The market read

The announcement details a challenging quarter with an EBITDA loss due to high input costs, but also highlights recovery signs in certain segments and positive future outlook. The overall sentiment is neutral as it balances negative financial results with positive future expectations and ongoing operational developments.

Chemplast Sanmar Limited has released the transcripts of its Earnings Conference Call held on August 7, 2026. The call, which discussed Q1 FY27 results, highlighted a volatile global environment impacting raw material availability and costs.

The company reported a consolidated revenue of ₹1,125 crore for the quarter, but faced an EBITDA loss of ₹115 crore due to a sharp increase in input costs. The Paste PVC segment experienced volatile demand initially due to supply issues and elevated input costs, but saw market recovery in June. The company is pursuing legal action regarding anti-dumping duties against imports from the European Union and Japan. A 7,000-ton debottlenecking project at the Cuddalore Paste PVC facility is on track for October 2026 commissioning.

The Custom Manufactured Chemicals Division (CMCD) showed improved performance with a healthy order book and accelerating customer engagements. The company is confident in the business's continued momentum through FY27, with expansion in its molecule pipeline to nearly 50, and 14 commercialized. The refrigerant gas business is progressing, with commercial production of R32 commencing in May 2026 and new plant commissioning underway.

The value-added chemicals business, including caustic soda and chloromethane, operated in a challenging market with pricing pressure. Hydrogen peroxide volumes improved sequentially. An incident occurred on July 17, 2026, at the PVC plant in Karaikal, resulting in a manual shutdown, with operations expected to be restored safely and timely.

Suspension PVC business faced headwinds from declining prices and elevated VCM prices due to Middle East conflict and feedstock availability issues. The company is exploring strategic priorities to enhance long-term value for stakeholders. Financially, consolidated revenue was ₹1,125 crore, with a net loss of ₹1,76 crore. Segment-wise, Specialty Chemicals reported ₹427 crore revenue, Value-added chemicals ₹129 crore, and Suspension PVC ₹569 crore.

Management discussed that high-cost VCM inventory impacted Q1 and is expected to be consumed by August. Future spreads for Suspension PVC are anticipated to be around $160, with Paste PVC spreads around $200. The company expects improved performance from Q3 onwards.

Filing to action

What to do with a filing like this

Chemplast Sanmar Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Chemplast Sanmar Limited. Read the original for the full detail.

View original filing